Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thrombolytic stroke therapy: past, present, and future.

J A Zivin1

  • 1Department of Neurosciences, University of California, San Diego, La Jolla 92093-0624, USA. jzivin@ucsd.edu

Neurology
|July 17, 1999
PubMed
Summary

Acute stroke treatment has shifted from recurrence prevention to rapid intervention. Tissue plasminogen activator offers hope, with future strategies combining thrombolytics and neuroprotectants.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

NeuroThera® Efficacy and Safety Trial-3 (NEST-3): a double-blind, randomized, sham-controlled, parallel group, multicenter, pivotal study to assess the safety and efficacy of transcranial laser therapy with the NeuroThera® Laser System for the treatment of acute ischemic stroke within 24 h of stroke onset.

International journal of stroke : official journal of the International Stroke Society·2012
Same author

The STRokE DOC trial technique: 'video clip, drip, and/or ship'.

International journal of stroke : official journal of the International Stroke Society·2008
Same author

Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study.

Neurology·2007
Same author

Baicalein, an antioxidant 12/15-lipoxygenase inhibitor improves clinical rating scores following multiple infarct embolic strokes.

Neuroscience·2007
Same author

Editorial commentary.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2007
Same author

Combination treatment for acute ischemic stroke: A ray of Hope?

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2007

Area of Science:

  • Neurology
  • Emergency Medicine
  • Pharmacology

Background:

  • Historically, stroke management focused solely on secondary prevention.
  • The introduction of tissue plasminogen activator (tPA) marked a paradigm shift in acute stroke care.
  • Treatment development and recommendations for tPA have faced challenges and controversy.

Purpose of the Study:

  • To review the evolving landscape of acute stroke treatment.
  • To highlight the impact of tissue plasminogen activator on patient management.
  • To discuss future directions in stroke therapy.

Main Methods:

  • Review of clinical trials and treatment guidelines.
  • Analysis of the impact of thrombolytic therapy.
  • Discussion of emerging therapeutic strategies.

Main Results:

  • Tissue plasminogen activator has demonstrated efficacy in acute stroke management.
  • Successful clinical trials support the use of thrombolytic agents.
  • Rapid initiation of treatment remains critical for positive outcomes.

Conclusions:

  • Acute stroke management has transitioned to include rapid intervention with agents like tPA.
  • Future stroke treatments are likely to involve combination therapies, including thrombolytics and neuroprotectants.
  • Timeliness of treatment initiation post-stroke onset is paramount.

Related Experiment Videos